Fulgent Genetics, Inc. (FLGT)

NASDAQ: FLGT · IEX Real-Time Price · USD
29.82
+0.02 (0.07%)
Mar 30, 2023, 11:16 AM EDT - Market open
0.07%
Market Cap 882.02M
Revenue (ttm) 618.97M
Net Income (ttm) 143.40M
Shares Out 29.52M
EPS (ttm) 4.63
PE Ratio 6.43
Forward PE 7.94
Dividend n/a
Ex-Dividend Date n/a
Volume 18,242
Open 30.01
Previous Close 29.80
Day's Range 29.79 - 30.30
52-Week Range 28.53 - 65.17
Beta 1.61
Analysts Buy
Price Target 42.50 (+42.52%)
Earnings Date May 2, 2023

About FLGT

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related var... [Read more]

Sector Healthcare
IPO Date Sep 29, 2016
Employees 645
Stock Exchange NASDAQ
Ticker Symbol FLGT
Full Company Profile

Financial Performance

In 2022, FLGT's revenue was $618.97 million, a decrease of -37.64% compared to the previous year's $992.58 million. Earnings were $143.40 million, a decrease of -71.74%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for FLGT stock is "Buy." The 12-month stock price forecast is $42.5, which is an increase of 42.52% from the latest price.

Price Target
$42.5
(42.52% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year?

Here is how Fulgent Genetics, Inc. (FLGT) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.

3 days ago - Zacks Investment Research

Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year?

Here is how Fulgent Genetics, Inc. (FLGT) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.

2 weeks ago - Zacks Investment Research

Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.29% and 13.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto...

1 month ago - Zacks Investment Research

Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”, or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therape...

1 month ago - Business Wire

Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeu...

1 month ago - Business Wire

Fulgent to Participate in the Raymond James & Associates' 44th Annual Institutional Investors Conference

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic devel...

1 month ago - Business Wire

Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing and therapeutics company focused on transforming patient ca...

1 month ago - Business Wire

NOTICE For Investors In NASDAQ: FLGT: Lawsuit Against Fulgent Genetics, Inc. Announced by Shareholders Foundation

San Diego, California--(Newsfile Corp. - January 24, 2023) -  The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) share...

2 months ago - Newsfile Corp

INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.'s Directors and Officers for Breach of Fiduciary Duties – FLGT

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of cert...

2 months ago - Business Wire

Fulgent Expands Board of Directors with Addition of Reggie Groves

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of Reggie Groves to its board of directors, ...

3 months ago - Business Wire

My Top 7 Strong Conviction Buys for 2023

Investors who avoided losing money this year are positioned to consider stocks that are strong conviction buys. An investment idea earns that level of faith when management demonstrates a consistent h...

3 months ago - InvestorPlace

Fulgent Genetics Stock (FLGT) - Fulgent Investors May Have Legal Claims And Are Encouraged to Contact Kehoe Law Firm, P.C. - Breach of Fiduciary Duties Investigation

Philadelphia, Pennsylvania--(Newsfile Corp. - December 6, 2022) - Kehoe Law Firm, P.C. is investigating whether the directors and/or officers of Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) breac...

4 months ago - Newsfile Corp

The 7 Best Mid-Cap Stocks to Buy Right Now

While the large-capitalization firms attract massive institutional support and the small enterprises grab retail eyeballs, the center lane investments – even those labeled the best mid-cap stocks to b...

Other symbols: ARCBLPXSIMOVIPSWFGWGO
4 months ago - InvestorPlace

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.'s Directors and Officers for Breach of Fiduciary Duties – FLGT

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating certain directors and officers of Fulge...

4 months ago - Business Wire

FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 21, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulg...

4 months ago - Accesswire

FLGT FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors With Losses Over $50K to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT

New York, New York--(Newsfile Corp. - November 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between...

4 months ago - Newsfile Corp

Fulgent Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 21, 2022 to Discuss Your Rights - FLGT

New York, New York--(Newsfile Corp. - November 21, 2022) - Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities l...

4 months ago - Newsfile Corp

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - November 21, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics...

4 months ago - Newsfile Corp

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022

NEW YORK , Nov. 21, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on...

4 months ago - PRNewsWire

FLGT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit

Radnor, Pennsylvania--(Newsfile Corp. - November 19, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed a...

4 months ago - Newsfile Corp

DEADLINE MONDAY NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 18, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulg...

4 months ago - Accesswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of inv...

4 months ago - Business Wire

Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit

RADNOR, Pa. , Nov. 18, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Ge...

4 months ago - PRNewsWire

DEADLINE MONDAY REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - November 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics...

4 months ago - Newsfile Corp

FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022

NEW YORK , Nov. 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT). To rece...

4 months ago - PRNewsWire